Navigation Links
Cara Therapeutics Announces Successful Completion of Phase I Clinical Trial of Novel Analgesic, CR845
Date:8/5/2008

SHELTON, Conn., Aug. 5 /PRNewswire/-- Cara Therapeutics, Inc. today announced completion of a Phase I clinical trial for its second-generation, peripherally acting kappa opioid agonist, CR845, under development for the treatment of acute and chronic pain. The drug candidate was safe and well-tolerated after intravenous infusion, and resulted in plasma levels of CR845 expected to be associated with clinical analgesic activity. In addition, CR845 infusion triggered a quantitative endocrine biomarker of peripheral kappa opioid receptor activation at the lowest dose tested.

The Phase Ia single-center clinical trial evaluated the safety, tolerability, pharmacokinetic profile, and pharmacological activity of CR845 in a double-blind, randomized, placebo-controlled, single escalating intravenous dose study in 54 healthy male and female volunteers. CR845 was shown to be safe at all doses investigated, with no reports of serious side effects or adverse central nervous system activity. Linear, dose-proportional increases in systemic exposure to CR845 were observed. Low doses of CR845 resulted in plasma levels at or above the plasma levels of drug expected to be associated with clinical analgesic efficacy.

The Company plans to advance its intravenous formulation of CR845 into Phase II trials later in 2008. Based on the demonstrated safety, tolerability, and bioactivity of this formulation in Phase I, Cara will continue to develop its oral formulation of CR845 for advancement into Phase I.

About CR845

CR845 was designed to be highly selective for the peripheral kappa opioid receptor, with a prolonged duration of action relative to Cara's first generation of peripheral kappa opioids. Animal studies indicate that CR845 is effective in reducing pain of inflammatory, neuropathic and visceral origin. The analgesic and anti-inflammatory effects of CR845 lasted for up to 18 hours after a single dose. CR845 was active after intravenous, subcutaneous, o
'/>"/>

SOURCE Cara Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
2. Nile Therapeutics Announces Dosing in Second Phase Ib Study of CD-NP in Heart Failure Patients
3. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
4. Echo Therapeutics Announces Positive Results of a Clinical Study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
5. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
6. Michael J. Fox Foundation Awards $2.7 Million for Industry Efforts to Speed New Parkinsons Therapeutics
7. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
8. Halozyme Therapeutics Announces Positive Findings With Pegylated Enzyme in Prostate Cancer Models
9. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
10. Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors
11. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 28, 2014  ALPHAEON Corporation ® ... and subsidiary of Strathspey Crown Holdings ... Nutriceuticals (PRN) ® , a leading developer ... for dry eye and macular degeneration, ... worth up to $55M. ...
(Date:7/28/2014)... MUNICH , July 28, 2014  ResMed (NYSE: ... developing products for the treatment of sleep-disordered breathing and ... in Germany against Taiwanese medical ... infringing headgear used on APEX WiZARD 210 and 220 ... Court in Munich , is appealable, ...
(Date:7/28/2014)... , July 28, 2014   Cardioxyl Pharmaceuticals, ... clinical trial demonstrating that CXL-1427, a novel potential treatment ... in healthy volunteers. The company has now initiated dosing ... Phase IIa clinical trial designed to further evaluate the ... levels. The Phase I clinical trial evaluated ...
Breaking Medicine Technology:ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 2ALPHAEON Acquires PRN, A Leading Specialty Nutriceutical Company 3ResMed Receives Permanent Injunction against APEX in Germany, Continues Enforcement of Patents in Europe 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2
... , CARSON CITY, Nev. , ... the launch of www.BionicCigs.com , the premiere website for ... this exciting new product that helps smokers wishing to quit and ... electronic cigarette market is estimated to be a $100 Million ...
... , Feb. 2 Advanced Health Media, LLC ... compliance technology and services, announced it has acquired substantially all ... Piscataway, NJ -based provider of marketing services for the pharmaceutical ... will remain at AHM,s Bridgewater, N.J. office. Terms ...
Cached Medicine Technology:Rapid Fire Marketing Enters Electronic Cigarette Market 2Advanced Health Media Acquires Advogent 2Advanced Health Media Acquires Advogent 3
(Date:7/28/2014)... Charlotte, NC (PRWEB) July 28, 2014 ... actively responded to the all-too-often stories in the media ... Death can occur in a matter of minutes in ... Day, according to the Office of Emergency Medical Services ... Precious Cargo app for smartphones. Realizing that it’s all ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 According ... Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition ... ALD), Product (Power, Opto-electronic), Application, and Geography-2013-2020", published ... at a CAGR of 12.63% from 2014 to ... Browse 121 market data tables and 88 figures ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 The ... the graduates of its Advanced Training Program in ... fill roles in their health care organization ranging ... and methodology of continuous quality improvement in the ... to Dr. Brent James’ internationally recognized Advanced Training ...
(Date:7/28/2014)... 28, 2014 The Europe Carotenoids & ... antioxidants market in Europe with analysis and forecast of ... in 2012 to $765.93 million by 2018, at a ... through the TOC of the Europe Carotenoids & Antioxidants ... analysis provided. It also provides a glimpse of the ...
(Date:7/28/2014)... North Carolina State University is proposing a new theory ... with age, but don,t necessarily show declines in the ... how motivated older adults are to maintain focus on ... to explain the difference we see in cognitive performance ... of psychology at NC State and author of a ...
Breaking Medicine News(10 mins):Health News:'Precious Cargo' App Released to Help Save Babies from the Dangers of Being Accidentally Left Behind in Hot Cars 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 2Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 3Health News:Compound Semiconductor Market by Type (III-V, II-VI, IV-IV, sapphire), Deposition Technology, Product Worth $104.55 Billion in 2020 - New Report by MarketsandMarkets 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Carotenoids & Antioxidants (Nutraceuticals) Market is Expected to Reach $765.93 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2
... Nurses Now Available Online , , SKILLMAN, N.J., ... of innovative medical technologies for community and hospital care, ... an online, interactive community and resource. The resource ... providers and will be unveiled at the 41st Annual ...
... What Mom and Dad consume has little effect on ... News) -- Parents, eating habits don,t seem to influence ... thought, new research suggests. , "We found that the ... weak," said study senior author Dr. Youfa Wang, an ...
... for drying hands , , PHILADELPHIA, June 5 In ... percent of U.S. adults said they always wash their hands after ... they thought washed their hands each time after using a public ... do so each time, and almost half (48 percent) felt that ...
... , HOUSTON, June 5 The Senior Citizens ... with over 500,000 members, has established two new divisions: ... , , These two new divisions will bring ... the goal of better educating and empowering their senior ...
... ... they have mutually decided to terminate their contractual relationship. Effective as of June 1, ... to provide ongoing group purchasing and supply chain management services. , ... Brentwood, Tenn. and Hemet, Calif. (PRWEB) ...
... ... in Dentistry DVD is a new DVD produced by Dr. Paul ... to prevent provisional restorations for dental crowns, bridges and veneers from ... dental laboratory. It teaches dentists, dental assistants and expanded duty ...
Cached Medicine News:Health News:ConvaTec Launches New Programs to Support and Recognize WOC Nursing 2Health News:ConvaTec Launches New Programs to Support and Recognize WOC Nursing 3Health News:Parental Eating Habits Don't Rub Off on Kids 2Health News:National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms, But Most Think They Are Exception 2Health News:National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms, But Most Think They Are Exception 3Health News:National Survey Finds Nearly All Adults Say They Wash Their Hands After Visiting Public Restrooms, But Most Think They Are Exception 4Health News:Senior Citizens Bureau Creates New Resourceful Divisions 2Health News:QHR and Valley Health Amicably Part Ways 2Health News:New ... Provisional Restorations In Dentistry DVD by Paul R. Chalifoux, DDS 2
The Spinchron 15 centrifuge provides all the versatility and high capacity needed for today's full-service clinical lab needs. This centrifuge is available in a nonrefrigerated model with a speed up ...
... microscopes utilize the infinity-corrected optical ... operability in cell checking. The ... microscope suited to routine applications ... tissue culture and embryology to ...
... Our unique Lollipop lens handle ... without touching the lens itself. Lenses ... panels of black and white with ... in various base/top color: black, red, ...
The simplest, neatest, most efficient anti-theft system for frames and sunwear. Available in 3 colors Black, Matte aluminum, and Bronze. Fits with any style or color of furniture. Safe, simple, easy...
Medicine Products: